Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

FDA alerts patients and health care professionals that a clinical trial evaluating Pepaxto (melphalan flufenamide) showed an increased risk of...

FDA amended the EUA for the Pfizer-BioNTech COVID-19 Vaccine to allow for the use of a single booster dose in certain...

  • FPM

    The FDA has approved booster doses of Pfizer's COVID-19 for people 65+, or those at high risk for COVID complications due to medical condition or occupational exposure. The boosters are to be given six months after the second dose. https://t.co/uNIoz6N9f9 - view on twitter

FDA approves Repatha (evolocumab) injection as an add-on treatment for patients aged 10 years and older with HeFH and...

The FDA took steps aimed at improving the quality, safety, and efficacy of...

FDA amended the EUA for the Pfizer-BioNTech COVID-19 Vaccine to allow for the use of a single booster dose in certain...

The FDA has a variety of programs and information resources available for patients with cancer and patient...

FDA amended the EUA for the Pfizer-BioNTech COVID-19 Vaccine to allow for the use of a single booster dose in certain...

Joy Gourmet Foods Inc. of Maspeth, NY is recalling its Joy Brand.Coriander chutney because it contains undeclared sulfites.coconut. FD&C YELLOW#5 . People who have...

The FDA is providing this initial list of AI/ML-enabled medical devices marketed in the United States as a resource to the...

When it comes to planning for emergencies, pet owners should consider their pets...